|
H1F0 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.101600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.113900E-02 |
| Normal-vs-Stage2 |
8.242700E-03 |
| Normal-vs-Stage3 |
1.480420E-03 |
| Normal-vs-Stage4 |
2.394900E-04 |
| Stage1-vs-Stage2 |
9.477900E-02 |
| Stage1-vs-Stage3 |
1.398240E-04 |
| Stage1-vs-Stage4 |
3.21989999996219E-06 |
| Stage2-vs-Stage3 |
1.250170E-01 |
| Stage2-vs-Stage4 |
6.419300E-03 |
| Stage3-vs-Stage4 |
2.046200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.272400E-02 |
| Normal-vs-AfricanAmerican |
1.302220E-02 |
| Normal-vs-Asian |
4.422700E-03 |
| Caucasian-vs-AfricanAmerican |
2.879800E-01 |
| Caucasian-vs-Asian |
8.021800E-02 |
| AfricanAmerican-vs-Asian |
1.532770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.462300E-02 |
| Normal-vs-Female |
1.485700E-02 |
| Male-vs-Female |
2.945600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.683900E-03 |
| Normal-vs-Extreme_Weight |
3.630400E-02 |
| Normal-vs-Obese |
1.312100E-02 |
| Normal-vs-Extreme_Obese |
5.245600E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.340020E-02 |
| Normal_Weight-vs-Obese |
3.654200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.448240E-01 |
| Extreme_Weight-vs-Obese |
1.279450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.934800E-01 |
| Obese-vs-Extreme_Obese |
4.182800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.223900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.599500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.767870E-02 |
| Normal-vs-Age(81-100Yrs) |
1.968400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.056800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.481000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.884000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.675600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.461800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.919000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.070400E-02 |
| Normal-VS-Type2 PRCC |
1.662500E-03 |
| Normal-VS-KIRP CIMP |
4.15289999999846E-05 |
| Normal-VS-Unclassified PRCC |
2.976300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.43840503344472E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.74820000090159E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.046800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.024200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.013000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.79919999799117E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.655900E-03 |
| Normal-vs-N1 |
5.968300E-04 |
| Normal-vs-N2 |
1.847610E-04 |
| N0-vs-N1 |
7.111800E-02 |
| N0-vs-N2 |
1.152640E-01 |
| N1-vs-N2 |
6.209800E-01 |
|
|
